Transdermal therapeutic system TTS containing tolterodine
Patent 6783769 Issued on August 31, 2004. Estimated Expiration Date: 
May 16, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
May 16, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesDermal therapeutic system made of a meltable poly (meth) acrylate Patent #: 5730999 InventorsAssigneeApplicationNo. 10009644 filed on 05/16/2000US Classes:424/449, Transdermal or percutaneous424/443, Web, sheet or filament bases; compositions of bandages; or dressings with incorporated medicaments424/484, Matrices424/487, Acrylic acid and derivatives424/448Pressure sensitive adhesive meansExaminersPrimary: Page, Thurman K.Assistant: Ghali, Isis Attorney, Agent or FirmForeign Patent References
International ClassesA61F 1300A61F 1302 A61K 914 A61L 1516 AbstractThe invention relates to a transdermal therapeutic system (TTS) for transcutaneously administering tolterodine over a period of several days and to a method for producing the same. The TTS contains a self-adhesive layer-shaped matrix composition which contains a (meth)acrylate copolymer comprising ammonium groups. The TTS also contains at least one plasticizer and up to 25 wt, % of tolterodine. | |
